Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes
By C. Hicks, E. Selvin. Current Diabetes Reports, 2019
659 citations recorded by the source corpus.
Diabetic peripheral neuropathy eventually affects nearly 50% of adults with diabetes during their lifetime and is associated with substantial morbidity including pain, foot ulcers, and lower limb amputation. This review summarizes the epidemiology, risk factors, and management of diabetic peripheral neuropathy and related lower extremity complications. The prevalence of peripheral neuropathy is estimated to be between 6 and 51% among adults with diabetes depending on age, duration of diabetes, glucose control, and type 1 versus type 2 diabetes. The clinical manifestations are variable, ranging from asymptomatic to painful neuropathic symptoms. Because of the risk of foot ulcer (25%) and amputation associated with diabetic peripheral neuropathy, aggressive screening and treatment in the form of glycemic control, regular foot exams, and pain management are important. There is an emerging focus on lifestyle interventions including weight loss and physical activity as well. The American Diabetes Association has issued multiple recommendation statements pertaining to diabetic neuropathies and the care of the diabetic foot. Given that approximately 50% of adults with diabetes will be affected by peripheral neuropathy in their lifetime, more diligent screening and management are important to reduce the complications and health care burden associated with the disease.
Subfields: Endocrinology, Diabetes and Metabolism, Neurology, Physiology
View Paper: https://www.semanticscholar.org/paper/b10484a6f05b28f567804b66f75a856d8b1dcfad
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Yue Liu
- Keji Chen
- Mengqi Gao
- Luqi Huang
- Wenting Wang
- Yanfei Liu
- Shiwei Liu
- Yiwen Li
Citations in the corpus
- Diabetic vascular diseases: molecular mechanisms and therapeutic strategies (2023, background): “The chronic course of DM might have further adverse effects under poor glycemic control.(260,261) An increase in postprandial glucose plays an important role in the development of peripheral vascular disease in DM.”